Labcorp to spin off clinical-development business
July 28 (Reuters) - Laboratory Corp of America Holdings LH.N said on Thursday it would spin off its wholly-owned business focused on clinical drug trials into two new publicly traded companies. (Reporting by Mrinalika Roy in Bengaluru; Editing by Vinay Dwivedi) ((mrinalika.roy@thomsonreuters.com;))
Recent news on Laboratory of America Holdings
See all newsBrief: Labcorp To Announce Second Quarter 2026 Financial Results On July 30, 2026
Brief: Labcorp And Epic Expand Collaboration To Advance Diagnostic Integration Across Hospitals And Health Systems
U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, Avis
Labcorp lifts full‑year forecast as diagnostics business stays resilient (updated)
U.S. STOCKS ON THE MOVE-Qualcomm, Meta, Cardinal Health